序号 |
标题 |
次数 |
作者 |
发布时间 |
84466 |
1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸-Ser-Ser-Ser-LTVSPWY |
101 |
zcy |
2024-11-22 |
84467 |
CAS号:474424-15-2,dota-pnp |
90 |
kx |
2024-11-22 |
84468 |
CU-64 DOTA-TATE |
105 |
zyl |
2024-11-22 |
84469 |
DOTA-hLL2 螯合剂DOTA偶联人源化抗体hLL2 |
104 |
zcy |
2024-11-22 |
84470 |
DOTA-PSMA-EB-01 |
93 |
zyl |
2024-11-22 |
84471 |
1610950-41-8,DOTA-MeTz,DOTA-甲基四嗪 |
92 |
kx |
2024-11-22 |
84472 |
p-NCS-benzyl-DOTA p-NCS-苄基-DOTA |
140 |
zcy |
2024-11-22 |
84473 |
1189194-64-6,DOTA-(COOt-Bu)3-CH2-Alkynyl |
72 |
kx |
2024-11-22 |
84474 |
DOTA-cyclo(RGDfK);DOTA-RGD |
91 |
wyh |
2024-11-22 |
84475 |
CuAAC修饰的DOTAZA 齐岳定制 |
109 |
zcy |
2024-11-22 |
84476 |
1039726-31-2,DOTA-JR-11 |
75 |
kx |
2024-11-22 |
84477 |
zher2-HSA-DOTA DOTA螯合剂偶联ZHER2支架多肽缀合人血清白蛋白 |
116 |
zcy |
2024-11-22 |
84478 |
CAS:1800229-46-2 Maleimide-DOTA-GA |
87 |
zyl |
2024-11-22 |
84479 |
panitumumab-DOTA DOTA标记的抗EGFR帕尼单抗 |
84 |
zcy |
2024-11-22 |
84480 |
DOTA-CH2-Ph-azide(HCl salt) |
82 |
kx |
2024-11-22 |
84481 |
DOTA-三(酸) - 酰氨基-DPEG(R)11-马来酰亚胺 |
100 |
zyl |
2024-11-22 |
84482 |
DOTA-Glu「cyclo(Arg-Gly-Asp-D-Phe-Lys)」2 |
91 |
kx |
2024-11-22 |
84483 |
CAS:834870-39-2 DOTA series |
92 |
zyl |
2024-11-22 |
84484 |
DOTA-cyclo(RGDfK);DOTA-RGD |
90 |
wyh |
2024-11-22 |
84485 |
DOTA-PEG-SH、DOTA-PEG-Thiol的结构组成 |
87 |
kx |
2024-11-22 |
84486 |
DTPA-bis anhydride,二亚乙基三胺五乙酸二酐 |
100 |
wyh |
2024-11-22 |
84487 |
NOTA-PEG5000-Mal ;NOTA PEG5 马来酰亚胺 |
74 |
wyh |
2024-11-22 |
84488 |
DOTA-E「c(RGDfK)2」 |
78 |
kx |
2024-11-22 |
84489 |
DOTA-L-Lys(SA。Pam)-PSMA-617 DOTA偶联二膦酸盐和PSMA抑制剂 |
97 |
zcy |
2024-11-22 |
84490 |
DOTA-E[c(RGDfK)2]的应用领域 |
99 |
kx |
2024-11-22 |
84491 |
DOTA-氟喹诺酮衍生物 DOTA-fluoroquinolone derivatives |
76 |
zcy |
2024-11-22 |
84492 |
DOTA-NHS |
141 |
kx |
2024-11-22 |
84493 |
p-SCN-Bn-DTPA,102650-30-6,1-(4-异硫氰酸酯)二乙炔三胺 |
82 |
wyh |
2024-11-22 |
84494 |
NOTA-PEG-RGD |
74 |
kx |
2024-11-22 |
84495 |
三叔丁基1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸;137076-54-1 |
107 |
wyh |
2024-11-22 |
84496 |
DOTA-PEG-CRGD的结构组成、应用领域 |
76 |
kx |
2024-11-22 |
84497 |
DOTA-MWCNT-Gd DOTA钆配合物修饰多壁碳纳米管 |
82 |
zcy |
2024-11-22 |
84498 |
817562-90-6,(R)-tert-Bu4-DOTAGA,(R)-DOTAGA-四叔丁酯 |
77 |
kx |
2024-11-22 |
84499 |
DOTA-四聚乙二醇-甲基四嗪 |
95 |
zyl |
2024-11-22 |
84500 |
DOTA-奥曲肽,DOTA-octreotide |
106 |
kx |
2024-11-22 |
84501 |
DOTA-五聚乙二醇-C4-二苯并环辛炔 |
68 |
zyl |
2024-11-22 |
84502 |
127985-74-4 ,p-SCN-Bn-DOTA |
98 |
kx |
2024-11-22 |
84503 |
DOTA-Glu[cyclo(Arg-Gly-Asp-D-Phe-Lys)]2,250612-06-7 |
81 |
wyh |
2024-11-22 |
84504 |
DOTA探针分子DOTA-EM7 |
80 |
kx |
2024-11-22 |
84505 |
DOTA-四聚乙二醇-二苯并环辛炔;DSPE-PEG4-DBCO |
84 |
wyh |
2024-11-22 |
84506 |
DOTA缀合RAWVAWR-NH2 DOTA-RAWVAWR-NH2 |
83 |
zcy |
2024-11-22 |
84507 |
DOTA-FYLEHPSGGLAV-OH |
76 |
kx |
2024-11-22 |
84508 |
Fmoc-L-Lys-mono-amide-DOTA-tris(t-Bu ester),479081-06-6 |
72 |
wyh |
2024-11-22 |
84509 |
锕系元素(ⅲ)-DOTA配合物 Actinide(III)-DOTA Complexes |
90 |
zcy |
2024-11-22 |
84510 |
DOTA-PEG8-NHCO-MeTz |
76 |
zyl |
2024-11-22 |